AstraZeneca succession sickness demands urgent fix
Can a CEO be worth $9 billion? That’s the question posed by the 4% fall in AstraZeneca’s shares following an article stating boss Pascal Soriot may soon resign. The company has played down the report, and its stock has recovered, but the episode highlights its uncertain position were 64-year-old…
#astrazeneca #pascalsoriot #anglo #swedish #pfizer #lynparza #novartis #gsk #ftse #takediageo